Angeliki Roussaki‐Schulze

Pharmacogenetic Analysis of TNF, TNFRSF1A, and TNFRSF1B Gene Polymorphisms and Prediction of Response to Anti-TNF Therapy in Psoriasis Patients in the Greek Population

Yiannis Vasilopoulos, Marilena Manolika, Efterpi Zafiriou et al. · Molecular Diagnosis & Therapy · 2012 · 77 citations

Life Sciences, Genetics, Immunology +17

Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study*

Dédée F. Murrell, Aikaterini Patsatsi, P. Stavropoulos et al. · British Journal of Dermatology · 2021 · 71 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Objective biophysical findings in patients with sensitive skin.

Angeliki Roussaki‐Schulze, Efterpi Zafiriou, D Nikoulis et al. · PubMed · 2005 · 50 citations

Life Sciences, Dermatology, Immunology +13

Curcumin mediates attenuation of pro-inflammatory interferon γ and interleukin 17 cytokine responses in psoriatic disease, strengthening its role as a dietary immunosuppressant

Dimitrios Ν. Skyvalidas, Αthanasios Mavropoulos, Sotirios G. Tsiogkas et al. · Nutrition Research · 2020 · 49 citations

Life Sciences, Dermatology, Immunology +17

Evaluation of cytokine serum levels in patients with plaque-type psoriasis.

Angeliki Roussaki‐Schulze, CONSTANTINE E. KOUSKOUKIS, Efthimia Petinaki et al. · PubMed · 2005 · 43 citations

Medicine, Dermatology, Immunology +13